Tumor microbiomes offer new insights for enhancing cancer therapies

Comprehensive review reveals the significant impact of tumor-resident bacteria on metastatic cancer, showing how microbiome genomes influence tumor biology, immune system response, and treatment effectiveness. It lays the groundwork for utilizing bacteria-focused therapies to complement traditional cancer treatments.

FDA approves Galderma’s Nemluvio to treat atopic dermatitis

Nemluvio is intended for individuals aged 12 years and above with moderate-to-severe atopic dermatitis. Credit: Kmpzzz/Shutterstock. The US Food and Drug Administration (FDA) has approved

December 16, 2024

Stronger Quads May Lower Risk for Knee Replacement Surgery

CHICAGO — Larger quadriceps relative to hamstrings may lower the risk of needing total knee replacement surgery, according to findings from the NIH’s Osteoarthritis Initiative.

November 30, 2023

Novel small molecule oral antiviral could be a game-changer in the fight against future pandemics

Obeldesivir (GS-5245), a novel investigational small molecule oral antiviral, represents a new tool in the ongoing effort to prepare for future pandemics.

June 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.